Polycomb group (PcG) 
Introduction
PcG proteins are epigenetic repressors important in the maintenance of transcriptional silencing. PcG proteins exist in 3 distinct complexes: PRC1, PRC2 and pleiohomeotic repressive complex (PhoRC). PRC2 has 4 constituent proteins: E(z), Su(z)12, Esc and Pcl in flies and Ezh2, Suz12, Eed and Phf1 in mammals (Fig. 1A) . Ezh2 is the enzymatic component of PRC2, catalysing methylation of lysine 27 of histone H3 (H3K27) [1] [2] [3] [4] , while Suz12 and Eed are required for complete function of Ezh2 and stable formation of the For personal use only. on October 3, 2017 . by guest www.bloodjournal.org From complex 5, 6 . Phf1 influences the enzymatic specificity of Ezh2, promoting trimethylation of H3K27 (H3K27me3) in preference to dimethylation (H3K27me2) 7 . Dimethylation is broadly distributed throughout the genome and is thought to have a structural role, whereas H3K27me3 is enriched on promoters and associated with transcriptionally silent regions [8] [9] [10] [11] .
There has been a vast expansion in the number of PRC1 components in mammals. PRC1
components include Bmi1 and Mel18 (orthologues of Drosophila Psc), Cbx2, 4, and 8
(orthologues of Drosophila Pc), Scmh1 and 2 (orthologues of Drosophila Scm), Phc1/Rae28, Phc2 and 3 (orthologues of Drosophila Ph) and Ring1A and Ring1B
(orthologues of Drosophila Ring) (Fig. 1A ). Ring1A and Ring1B are the enzymatic components of PRC1 responsible for the mono-ubiquitination of histone H2A at lysine 119 (H2AK119Ub) 12 , other components such as Bmi1 and Mel18 are able to stimulate this activity. H2AK119Ub is also associated with transcriptional repression [13] [14] [15] .
PhoRC is composed of the DNA binding transcription factor Yy1 (Drosophila Pho) and Sfmbt1 (Fig. 1A) . PhoRC is not known to possess any enzymatic activity. Rather, Sfmbt binds methylated histone residues 16 , and Yy1 is the only mammalian PcG protein with specific DNA binding activity 17 , suggesting that PhoRC may direct PRC1 or PRC2.
Some years ago the chromodomain of Drosophila Polycomb was shown to bind H3K27me3, leading to the hierarchical recruitment model (reviewed 18 ), where PRC2
trimethylates H3K27, leading to PRC1 recruitment and ubiquitination of H2AK119.
For personal use only. on October 3, 2017 . by guest www.bloodjournal.org From Several lines of evidence support this prevailing model: (i) a high degree of overlap between sites bound by PRC1 and PRC2 in human and mouse cells 9, 10, 19 (ii) the failure of Drosophila E(z) mutants to recruit PRC1 20 ; and (iii) a correlation between H3K27me3 levels and PRC1 recruitment and H2AK119Ub accumulation 21 . A growing number of reports now suggest that PRC1 and 2 may not always act in this fashion: PRC1 binds nucleosomes that lack N-terminal tails in vitro 22 ; PRC1 is recruited in PRC2 deficient mammalian cells 23 ; and genome-wide ChIP studies show PRC2 bound to loci devoid of PRC1 19 and vice versa 15 . These observations imply that the interaction between various
PRCs is complex.
Genome-wide ChIP studies suggest PRCs play a role in ES cells by repressing key developmental transcription factors 8, 9 , although they also play roles in adult neural, 
Materials and Methods

Mouse strains
All mice were on an inbred C57BL/6 background, unless otherwise stated. Mice carrying the Eed 3354 allele were purchased from Oak Ridge National Laboratories. The Eed 3354 point mutation was detected using an allelic discrimination assay (Table S5 ). The Ezh2
Del allele was generated from the Ezh2 fl allele and genotyped as previously described 31 .
Animal studies were approved by the Walter and Eliza Hall Institute Animal Ethics
Committee.
Haematological analyses
Analyses were performed essentially as previously described 26 Differential expression analysis was performed as described in Supplementary Methods. GEO accession number: GSE21404.
Gene set testing
The overlap of the current microarray results with previous experiments was assessed using mean-rank gene set enrichment tests. A Wilcoxon signed-rank test was used to assess whether each external gene set was highly ranked when all genes on the For personal use only. on October 3, 2017. by guest www.bloodjournal.org From microarrays were ordered from most to least differentially expressed using the current data.
Genuine association of expression profiles (GENAS)
A novel procedure, implemented in the GENAS function of the limma package, was applied to estimate correlations between the expression profiles of different mouse mutants. Each mutant was compared to wild-type, producing a set of log 2 -fold changes.
The GENAS analysis determines whether these fold changes are correlated between mutants, after allowing for estimation uncertainty. The method is a generalization of the limma empirical Bayes analysis 32 in which the moderated t-statistics are modelled using a multivariate t distribution. The biological correlation between the mutants was estimated from the prior correlation of the log 2 -fold changes in the Bayesian hierarchical model. In this way, the method is able to separate true biological correlation from technical correlation. The statistical significance of the correlation is assessed by a likelihood ratio test.
Romer gene set enrichment analysis
Gene set enrichment analysis (GSEA) is an approach which correlates a large database of 
Results
All core PRC2 components restrict HSC/progenitor population activity
To study the role of PRC2 components ( Fig. 2A) . Consistent results were seen in mice heterozygous or homozygous for each of the other PRC1 mutant alleles; where effects on platelet number were found, they were in the opposite direction to those of the Suz12 Plt8 allele (Fig. S1 ).
The long-term repopulating capacity of stem cells from the Bmi1 and Suz12 compound heterozygous animals was tested using 1:1 competitive transplants of bone marrow cells into lethally irradiated recipients (Fig. 2B ). Bmi1 and Suz12 compound heterozygous animals show a level of contribution to recipients similar to wild-type, and significantly lower than the elevated contribution seen for Suz12 single heterozygotes (p < 0.01, Fig.   2B ). These results show that Bmi1 and Suz12 have opposing activities in HSC/progenitor function. (Fig. 3C) suggested that the Yy1 +/-cells are compromised in their ability to contribute to maintenance of the stem cell compartment and to blood cell formation (Fig. 3C and data not shown) .
Yy1 as part of PhoRC enhances HSC/progenitor activity
To confirm the role of Yy1 in HSC/progenitors, we used shRNA mediated viral knockdown of Yy1 in fetal liver cells, followed by transplant into lethally irradiated recipients. At 6 to 12 months post-transplantation, the proportion of Yy1 knockdown cells decreased significantly compared with the input cells and the non-silencing control, across all cell lineages including LSK cells, and all hematopoietic organs (Fig. 3D) .
Consistent with the phenotype of Suz12 mutant mice, Suz12 knockdown cells displayed an increased contribution across all cell types and hematopoietic organs (data not shown), as shown previously 26 . Splenic B cells were isolated from recipient animals and knockdown of Yy1 and Suz12 confirmed in vivo in the shRNA containing (GFP positive) cells (Fig. S3) . These results confirm that Yy1 enhances HSC/progenitor activity and number, independent of its role in embryonic development.
Identification of gene sets differentially regulated by PRC1, PRC2 and PhoRC
Identification of genes differentially regulated by the PRCs in hematopoietic cells was 
/Arf locus is repressed by each complex in Gata-1 null megakaryocyte erythroid (G1ME) cells 42 . Using an in vitro competition assay between infected (GFP+) and uninfected (GFP-) cells, we found a mild selection against Suz12
shRNA infected cells and a strong selection against cells infected with shRNAs directed against Bmi1 or Yy1 (Fig. S4A ).
Infected and uninfected cells were sorted on days 4 and 7 post-infection, and analysed by qPCR for knockdown of Bmi1, Yy1 and Suz12, and for expression of Cdkn2a (p16 Ink4a ) (Fig. S4B) . Each hairpin produced greater than 80% knockdown of the target (Fig. S4B ).
We did not observe any difference in Cdkn2a expression between cells uninfected and infected with the Nonsil or Suz12 shRNAs, but found significant up-regulation of Cdkn2a expression in cells infected with one Yy1 shRNA and the Bmi1 shRNA, and a small but not statistically significant increase in a different Yy1 shRNA (Fig. S4B) . Given the potency of p16
Ink4A
, increases in Cdkn2a need only be modest to slow growth of the cell and bring about a halt in cell cycle progression. Although Suz12 knockdown did not alter Cdkn2a expression in G1ME cells (Fig. S4B) , knockdown was effective since we observe changes in three other genes we previously found to be sensitive to Suz12 dose in LSK or Lin -c-Kit + cells (Fig. S5 ) 26 . This suggests that the Ink4a/Arf locus is differentially sensitive to the amount of Suz12, Bmi1 and Yy1 in the G1ME hematopoietic cell line.
To test whether changes in G1ME cells also occurred in LSK cells, we analysed Cdkn2a expression by qPCR in fetal liver LSK cells sorted from individual E14.5 embryos (Fig.   S6A ). Cdkn2a was undetectable in wild-type fetal liver LSKs, more than 1000 times 26 , and G1ME cells (Fig. S5) ; Prr6 was up-regulated in fetal liver LSK cells mutant for PRC1, PRC2 or PhoRC (Fig. S6B ). and very few genes with opposing expression changes, consistent with these factors cooperating to regulate gene expression in HSC/progenitors. To select specific genes, we applied a log 2 -fold-change cut off of 0.25. This identified 128 genes that were upregulated in fetal liver LSK cells depleted for either Bmi1 or Suz12 (Fig. 4A, coloured For personal use only. on October 3, 2017. by guest www.bloodjournal.org From blue , Table S2 ), that is, repressed by both PRC1 and PRC2. A larger set of 172 genes are up-regulated in fetal liver LSK cells depleted for Suz12 but down-regulated in Bmi1 deficient LSK cells (Fig. 4A, coloured red, Table S2 ). PRC2 represses expression of these genes, whereas PRC1, directly or indirectly, enhances their transcription.
Since we could not account for the defects in
Reassuringly, these genes behave similarly in cells depleted for Yy1 as those depleted in Bmi1 (Fig. 4B) .
Our second novel statistical method is called Romer; a powerful tool that takes into account the large number of moderate gene expression changes, and performs competitive gene set tests using all of the gene sets from the Broad Institute's Molecular Signatures database 33 . We used Romer to analyse the classes of genes enriched in those co-ordinately or differentially regulated by PRC1, PRC2 and PhoRC (Table S3 ). All comparisons had significant enrichment for genes sensitive to histone deacetylase inhibitor treatment, indicating the deregulated genes were sensitive to epigenetic control. (Fig. 4C) . Genes repressed by Bmi1 and up-regulated by Suz12 (yellow genes, Fig. 4A ) were enriched for genes up-regulated in the absence of Dnmt1, along with genes repressed by HoxA9 and C/EBPα (Fig. 4C) . Genes responsive to IL-6, a downstream target of C/EBPα, were also enriched within this group of genes.
We validated a small selection of the genes identified as co-ordinately or differentially
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From regulated by PRC1 and PRC2 by qPCR (Fig. S7 ). There were also gene sets co-ordinately regulated by PRC1 and PhoRC. Genes activated by C/EBP transcription factors were upregulated in the context of PRC1 or PhoRC depletion, as they were for PRC2 depletion (Fig. 4C) , unlike genes repressed by C/EBPα, which appear to be differentially regulated by PRC1 and PRC2. Genes that were co-ordinately down-regulated in the absence of Bmi1 or reduction of Yy1 (Fig. 4B) were enriched for hematopoiesis-related transcription factors and Hox genes (Fig. 4C ), in keeping with the defective HSC/progenitor activity of LSK cells depleted in Bmi1 or Yy1. These results confirm that depletion of PhoRC produces a similar molecular phenotype to deficiency in PRC1.
We extended our analyses to include adult LSK cells from Suz12
Plt8/+ animals, either replete or deficient for c-Mpl. We found a positive correlation between the gene expression changes identified in fetal and adult LSK cells (genes coloured blue, green, red and yellow in Fig. 4A , shown in Fig. S8 and ). These studies confirm the expression changes we observe in the fetal liver LSK compartment, and suggest that similar mechanisms govern the activity of PRCs in the adult stem cell compartment.
Discussion
In recent years, the role of PcG proteins in HSCs has been a subject of interest due to the clinical relevance of understanding the molecular mechanisms underpinning HSC activity, and the relationship between stem cell biology and cancer 43 . One puzzling finding has been that PRC1 components appear to enhance HSC function, while PRC2 components Suz12 and Eed restrict HSC and progenitor function, respectively 26, 27 ; results which are inconsistent with the predominant hierarchical model for PRC function. The molecular basis for the apparently opposing effects of PRC1 and PRC2 has remained elusive. Furthermore, any potential contribution of PhoRC to HSC biology had not been studied.
Here we analysed the role of PRC1, PRC2 and PhoRC in HSCs, and found that all core PRC2 components (Suz12, Ezh2 and Eed) are involved in restricting HSC/progenitor function. Overexpression of Ezh2 was previously shown to enhance HSC activity 44 . One potential explanation for this discrepancy was that Suz12 has a role outside of PRC2, however careful testing has revealed a similar phenotype in mutants of all three PRC2 components. We have confirmed that PRC1 and 2 have opposing roles in HSC/progenitors and shown that PRC1 and PRC2 do not synergise in their contribution to HSC/progenitor function. This finding is similar to previous observations in myeloid and B-lineage progenitors, using mutant alleles of Eed and the same knockout allele of Bmi1 27 . Therefore, at least at some loci critical to the function of HSCs (and progenitors), PRC1 may be targeted to chromatin via PRC2-independent mechanisms, consistent with afore mentioned studies in other cell types 9, 15, 23 . Our results suggest the loci where PRC1
and PRC2 act independently are important for HSC/progenitor function, and both the loci themselves and the mechanism of PRC action at these loci are worthy of further consideration.
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It is unclear how PRC1 may be targeted by PRC2-independent mechanisms or indeed how PRC2 is directed to specific loci, so we investigated the role of the only DNAbinding PcG protein, Yy1, in HSC function. Yy1 has a role in determining HSC/progenitor number and enhances HSC/progenitor function; PhoRC appears to play a PRC1-like role in HSC biology. Previous studies in other mammalian cell types have shown that Yy1 can associate with PRC1, PRC2 or both 45, 46 . Since Yy1 plays a similar role to PRC1 in HSC/progenitors, perhaps PhoRC directs PRC1 binding.
Given the differing roles of each of the PRCs in HSC/progenitors, we examined the genes controlled by each. We found that the Ink4a/Arf locus (specifically Cdkn2a expression) is differentially sensitive to the activity of PRC1, PRC2 and PhoRC in fetal liver LSK cells.
Our genome-wide expression analysis of these cells has led us to propose that PRCs have multiple potential modes of action, which can vary locus by locus (Fig. 4D) ; some genes are differentially sensitive to PRC dosage (eg. Cdkn2a), some are independently controlled by PRC1 with PhoRC or PRC2 alone (red and yellow genes), and others are co-ordinately controlled by PRC1, PhoRC and PRC2 (cooperative, blue genes).
Interestingly, genes that are co-ordinately regulated by all three PRCs show the largest fold changes, which may explain the focus on the hierarchical model. This has been misleading, however, as the opposing phenotypes we have observed, suggest that the more numerous but smaller fold changes seen in the genes independently controlled by each PRC are more important for HSC/progenitor function. Our results highlight the biological importance of small expression changes across gene sets. . Expression changes in C/EBP targets were generally consistent between the mutant genotypes; however, genes repressed by C/EBPα specifically, responded differentially to inhibition of PRC2 versus PRC1. One possible explanation for this result is that Bmi1 cooperates with C/EBPα to mediate silencing, and that this function is independent of PRC2. The described role for C/EBPα in HSCs fits with the differential changes we see in its targets in PRC1 compared with PRC2 mutants 49 .
Therefore, modest changes in the HoxA9 and C/EBPα transcriptional networks may explain some of the differences in the roles of the three PRCs in HSC/progenitors. One key challenge for the future will be to address the binding patterns of each complex in this rare but important cell type. may act independently at some loci, and other loci may be differentially sensitive to depletion of PRC1 (for example Bmi1) or PRC2 (for example Suz12).
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